https://www.selleckchem.com/pr....oducts/BMS-536924.ht
Arctigenin can be used as a lead compound for the development of lung adenocarcinoma therapy drugs. Over the last two decades, developments in nanomedicine have resulted in technical advances with application to clinical science. Both organic and inorganic nanoparticles (NPs) have shown tolerability, pharmacologic specificity and biodegradability. A subclass of NPs, protein NPs, have garnered recent attention due to the inherent biocompatibility of protein substrates. Protein NPs are currently being employed widely in pharmaceuticals
Like
Comment
Share
